Henry Schein (HSIC) Stock Forecast & Price Target

$69.82 +0.87 (+1.26%)

(As of 12/20/2024 05:31 PM ET)

Henry Schein - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 11 Analyst Ratings

Sell
0

Hold
6

Buy
5

Based on 11 Wall Street analysts who have issued ratings for Henry Schein in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 11 analysts, 6 have given a hold rating, 4 have given a buy rating, and 1 has given a strong buy rating for HSIC.

Consensus Price Target

$78.89
12.99% Upside

According to the 11 analysts' twelve-month price targets for Henry Schein, the average price target is $78.89. The highest price target for HSIC is $86.00, while the lowest price target for HSIC is $72.00. The average price target represents a forecasted upside of 12.99% from the current price of $69.82.

Get the Latest News and Ratings for HSIC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Henry Schein and its competitors.

HSIC Analyst Ratings Over Time

Type	Current Forecast 12/22/23 to 12/21/24	1 Month Ago 11/22/23 to 11/21/24	3 Months Ago 9/23/23 to 9/22/24	1 Year Ago 12/22/22 to 12/22/23
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	4 Buy rating(s)	5 Buy rating(s)	5 Buy rating(s)	5 Buy rating(s)
Hold	6 Hold rating(s)	5 Hold rating(s)	5 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$78.89	$78.89	$77.10	$79.25
Forecasted Upside	12.99% Upside	6.74% Upside	8.36% Upside	5.78% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

Trump’s Sending THIS Crypto Higher on Purpose (Ad)

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

YES, I WANT THE #1 CRYPTO NOW

HSIC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

HSIC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Henry Schein Stock vs. The Competition

Type	Henry Schein	Medical Companies	S&P 500
Consensus Rating Score	2.55	2.81	2.51
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	12.99% Upside	25,828.59% Upside	14.54% Upside
News Sentiment Rating	Positive News See Recent HSIC News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
12/4/2024	Mizuho 3 of 5 stars	S. Valiquette Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral	$75.00	-0.28%
11/6/2024	Barrington Research 4 of 5 stars		Reiterated Rating	Outperform ➝ Outperform	$82.00 ➝ $82.00	+17.43%
10/8/2024	Evercore ISI 2 of 5 stars		Boost Target	In-Line ➝ In-Line	$70.00 ➝ $74.00	+5.99%
8/12/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$88.00 ➝ $80.00	+17.20%
8/7/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$75.00 ➝ $72.00	+7.29%
8/7/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$92.00 ➝ $82.00	+21.68%
Genesis leading the smart algo revolution? (Ad) I’m revealing an exciting breakthrough that can help trade the markets unlike anything you’ve ever seen before… Because with my BRAND NEW smart algo you’ll always have a constant stream of alerts firing off in your back pocket to choose from. Here’s why: It does all the heavy lifting for you… automatically. Stock Ticker, Entry Price, Profit Target, Stop Loss, and even an Individual Chart! You’ll want to see what I’ve put on this page right here
7/22/2024	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Johnson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
6/21/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Overweight	$86.00 ➝ $86.00	+27.37%
3/6/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$74.00 ➝ $81.00	+7.41%
2/26/2024	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Cherny Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform
2/26/2024	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Market Perform	$78.00	-2.33%
11/27/2023	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$75.00	+9.91%
11/14/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Underweight ➝ Underweight	$69.00 ➝ $65.00	-3.90%
8/8/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$96.00	+26.53%
8/7/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$76.00 ➝ $75.00	-1.15%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 12:15 AM ET.

HSIC Forecast - Frequently Asked Questions

: According to the research reports of 11 Wall Street equities research analysts, the average twelve-month stock price forecast for Henry Schein is $78.89, with a high forecast of $86.00 and a low forecast of $72.00.
: 11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Henry Schein in the last year. There are currently 6 hold ratings, 4 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" HSIC shares.
: According to analysts, Henry Schein's stock has a predicted upside of 12.99% based on their 12-month stock forecasts.
: Henry Schein has been rated by research analysts at Barrington Research, Evercore ISI, and Mizuho in the past 90 days.
: Analysts like Henry Schein less than other "medical" companies. The consensus rating score for Henry Schein is 2.55 while the average consensus rating score for "medical" companies is 2.81. Learn more on how HSIC compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Cackling Kamala hates this company (Ad)

Do you want to see one of the most exciting election trades of all time? A trade that could help America become 100% energy independent… Reduce energy costs to virtually zero… And hand investors what could be a stunning return in just a few years’ time? It all has to do with a little known company that is helping to kick off the next great American energy revolution.

Before that happens, you need to see the details here.

This page (NASDAQ:HSIC) was last updated on 12/21/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Henry Schein (HSIC) Stock Forecast & Price Target